An update of new small-molecule anticancer drugs approved from 2015 to 2020.
作者： Xiaoxia Liang , Cheng Lv , Lixia Li , Lizi Yin , Bo Jing
DOI: 10.1016/J.EJMECH.2021.113473
关键词: Pharmacology 、 Original research 、 Cancer 、 Small molecule 、 Chemistry 、 Cyclin-dependent kinase 、 Cancer treatment 、 PTK Inhibitors 、 MAPK Inhibitors
摘要: … In September 2018, a small-molecule irreversible inhibitor of HER1, HER2, Dacomitinib, received the first global approval by US FDA, for use in the first-line treatment of patients with …
sci-hub.st 参考文章(360)
A Zaczek, K P Bielawski, B Brandt, The diverse signaling network of EGFR, HER2, HER3 and HER4 tyrosine kinase receptors and the consequences for therapeutic approaches. Histology and Histopathology. ,vol. 20, pp. 1005- 1015 ,(2005) , 10.14670/HH-20.1005
Daanish Hoda, Adil Daud, Protein Kinase Inhibitors Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures. pp. 319- 330 ,(2011) , 10.1007/978-90-481-9704-0_17
T. Knösel, E. Kampmann, T. Kirchner, A. Altendorf-Hofmann, Tyrosinkinasen in Weichgewebstumoren Pathologe. ,vol. 35, pp. 198- 201 ,(2014) , 10.1007/S00292-014-1958-3
Yasushi Yoshimura, Hiroshi Sakamoto, Tomohiro Tanaka, Naoto Inagaki, Megumi Uzu, アレクチニブ塩酸塩（アレセンサ®カプセル20 mg，同40 mg）の創製とその開発 Folia Pharmacologica Japonica. ,vol. 145, pp. 318- 324 ,(2015) , 10.1254/FPJ.145.318
Agata Kurzyk, [Angiogenesis - possibilities, problems and perspectives]. Postepy biochemii. ,vol. 61, pp. 25- 34 ,(2015)
Celeste B. Burness, Sonidegib: First Global Approval Drugs. ,vol. 75, pp. 1559- 1566 ,(2015) , 10.1007/S40265-015-0458-Y
W. Lee Kraus, PARPs and ADP-Ribosylation: 50 Years … and Counting Molecular Cell. ,vol. 58, pp. 902- 910 ,(2015) , 10.1016/J.MOLCEL.2015.06.006
Joginder Singh Bajwa, Raeann Wu, Stephanie Kay Dodd, Marilyn De La Cruz, Liladhar Murlidhar Waykole, Salts of N-[6-cis-2,6-Dimethylmorpholin-4-yl)pyridine-3-yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide ,(2009)
Elizabeth R. Tucker, Laura S. Danielson, Paolo Innocenti, Louis Chesler, Tackling Crizotinib Resistance: The Pathway from Drug Discovery to the Pediatric Clinic Cancer Research. ,vol. 75, pp. 2770- 2774 ,(2015) , 10.1158/0008-5472.CAN-14-3817